88 related articles for article (PubMed ID: 6532067)
1. [A study on immune response of regional lymph nodes in patients with lung cancer].
Sannoh K
Igaku Kenkyu; 1984 May; 54(6):695-709. PubMed ID: 6532067
[No Abstract] [Full Text] [Related]
2. Immune response of regional lymph nodes in patients with lung cancer.
Ogawa J; Inoue H; Koide S; Kawada S; Shohtsu A
Tokai J Exp Clin Med; 1981 Jul; 6(3):259-66. PubMed ID: 6975508
[TBL] [Abstract][Full Text] [Related]
3. [Evaluation of T- and B-cell immunity of regional lymph nodes in patients with skin melanoma and prognosis of the disease].
Serov AA; Kadagidze ZG
Vopr Onkol; 1983; 29(12):18-20. PubMed ID: 6607569
[TBL] [Abstract][Full Text] [Related]
4. [Immunomorphologic responses of regional lymph nodes and prognosis in patients with stage Ia pulmonary adenocarcinoma].
Takakura H; Hirohasi S; Shimosato Y; Kodama T; Kameya T; Naruke T; Suemasu K
Gan No Rinsho; 1983 Jun; 29(7):777-84. PubMed ID: 6876444
[TBL] [Abstract][Full Text] [Related]
5. [Immunomorphology of lymph nodes and prognosis in lung cancer].
Di Giorgio A; Sammartino P; Canavese A; Arnone P; Sibio S; Accarpio F; Al Mansour M
Minerva Chir; 2001 Apr; 56(2):153-9. PubMed ID: 11353348
[TBL] [Abstract][Full Text] [Related]
6. [Studies on immunosuppression in the patient with lung cancer: character and function of lymphocytes (author's transl)].
Inoue S
Hokkaido Igaku Zasshi; 1982 Jan; 57(1):87-100. PubMed ID: 7076110
[No Abstract] [Full Text] [Related]
7. Cellular immune competence of patients with lung cancer and other lung diseases. I. Analysis of peripheral blood lymphocyte subsets using monoclonal antibodies.
Fujiwara S; Akiyama M; Kobuke K; Ichimaru S; Takaishi M; Inamizu T; Kohno N; Takami S; Noumi K; Kawamoto M
Hiroshima J Med Sci; 1986 Sep; 35(3):227-36. PubMed ID: 3804783
[No Abstract] [Full Text] [Related]
8. Study of tumor-associated blastogenic reactivity of peripheral blood lymphocytes and regional lymph node lymphocytes in human malignancy.
Kurosu Y; Saegusa Y; Tominaga M; Morita K
Jpn J Clin Oncol; 1983 Mar; 13(1):25-30. PubMed ID: 6834651
[TBL] [Abstract][Full Text] [Related]
9. Quantitative and functional study of breast cancer axillary lymph nodes and those draining other human malignant tumors.
Di Girolamo V; Laguens RP; Coronato S; Salas M; Spinelli O; Portiansky E; Laguens G
J Exp Clin Cancer Res; 2000 Jun; 19(2):155-9. PubMed ID: 10965811
[TBL] [Abstract][Full Text] [Related]
10. Immunological approach in the evaluation of regional lymph nodes of patients with squamous cell carcinoma of the head and neck.
Verastegui E; Morales R; Barrera JL; Müeller A; Guzman B; Meneses A; Alfaro G
Clin Immunol; 2002 Jan; 102(1):37-47. PubMed ID: 11781066
[TBL] [Abstract][Full Text] [Related]
11. [Immunopathological studies on immunoglobulins of lymph nodes involved in lung neoplasms].
Oka Y
Bull Chest Dis Res Inst Kyoto Univ; 1975 Mar; 8(2):54-75. PubMed ID: 1164575
[No Abstract] [Full Text] [Related]
12. Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix.
Santin AD; Ravaggi A; Bellone S; Pecorelli S; Cannon M; Parham GP; Hermonat PL
Gynecol Oncol; 2001 Jun; 81(3):424-32. PubMed ID: 11371133
[TBL] [Abstract][Full Text] [Related]
13. [Immunosuppressive properties of the serum of patients with lung cancer].
Plucińska M; Mierzwa W; Stadnicki M; Byszewska D; Rykiel B; Olechnowicz H; Roszkowski W; Rowińska-Zakrzewska E
Pneumonol Pol; 1987 Sep; 55(9):393-400. PubMed ID: 3697317
[No Abstract] [Full Text] [Related]
14. Tumor-draining lymph nodes of primary lung cancer patients: a potent source of tumor-specific killer cells and dendritic cells.
Kimura H; Dobrenkov K; Iida T; Suzuki M; Ando S; Yamamoto N
Anticancer Res; 2005; 25(1A):85-94. PubMed ID: 15816523
[TBL] [Abstract][Full Text] [Related]
15. [Immunogenic activity of the regional lymphoreticulum during primary cancer of the lung].
Lenzini L; Barnabé R
Folia Allergol (Roma); 1969; 16(6):524-34. PubMed ID: 5401365
[No Abstract] [Full Text] [Related]
16. [Cell immunity factors in patients with lung cancer treated by the split-course schedule method].
Zhakov IG; Rybakov NI; Danilova TS; Pankina VKh
Vopr Onkol; 1980; 26(4):75-9. PubMed ID: 6966446
[TBL] [Abstract][Full Text] [Related]
17. Expression of HLA-DR is reduced in tumor infiltrating immune cells (TIICs) and regional lymph nodes of non-small-cell lung carcinomas. A putative mechanism of tumor-induced immunosuppression?
Foukas PG; Tsilivakos V; Zacharatos P; Mariatos G; Moschos S; Syrianou A; Asimacopoulos PJ; Bramis J; Fotiadis C; Kittas C; Gorgoulis VG
Anticancer Res; 2001; 21(4A):2609-15. PubMed ID: 11724329
[TBL] [Abstract][Full Text] [Related]
18. [The phenomenon of blastic transformation of lymphocytes in the immunology of neoplastic diseases].
Zhukhina GE
Vopr Onkol; 1972; 18(6):91-6. PubMed ID: 4559304
[No Abstract] [Full Text] [Related]
19. CD1c+ and CD303+ dendritic cells in peripheral blood, lymph nodes and tumor tissue of patients with non-small cell lung cancer.
Tabarkiewicz J; Rybojad P; Jablonka A; Rolinski J
Oncol Rep; 2008 Jan; 19(1):237-43. PubMed ID: 18097601
[TBL] [Abstract][Full Text] [Related]
20. [Functional activity of the regional lymph nodes in breast cancer patients].
Loboda VI; Grinevich IuA
Vopr Onkol; 1983; 29(2):31-6. PubMed ID: 6601329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
